BIIB logo

Biogen Inc. (BIIB) Cash from financing

annual CFF:

-$683.50M-$820.50M(-598.91%)
December 31, 2024

Summary

  • As of today (August 24, 2025), BIIB annual cash flow from financing activities is -$683.50 million, with the most recent change of -$820.50 million (-598.91%) on December 31, 2024.
  • During the last 3 years, BIIB annual CFF has risen by +$1.40 billion (+67.24%).
  • BIIB annual CFF is now -169.29% below its all-time high of $986.40 million, reached on December 31, 2015.

Performance

BIIB Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

quarterly CFF:

-$11.70M+$11.30M(+49.13%)
June 30, 2025

Summary

  • As of today (August 24, 2025), BIIB quarterly cash flow from financing activities is -$11.70 million, with the most recent change of +$11.30 million (+49.13%) on June 30, 2025.
  • Over the past year, BIIB quarterly CFF has increased by +$233.50 million (+95.23%).
  • BIIB quarterly CFF is now -100.40% below its all-time high of $2.91 billion, reached on September 30, 2015.

Performance

BIIB quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFF:

-$33.40M+$233.50M(+87.49%)
June 30, 2025

Summary

  • As of today (August 24, 2025), BIIB TTM cash flow from financing activities is -$33.40 million, with the most recent change of +$233.50 million (+87.49%) on June 30, 2025.
  • Over the past year, BIIB TTM CFF has increased by +$459.50 million (+93.22%).
  • BIIB TTM CFF is now -101.35% below its all-time high of $2.47 billion, reached on September 30, 2015.

Performance

BIIB TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BIIB Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-598.9%+95.2%+93.2%
3 y3 years+67.2%+97.5%+97.3%
5 y5 years+88.3%+99.1%+99.5%

BIIB Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-598.9%+67.2%-101.4%+99.1%-104.3%+98.1%
5 y5-year-598.9%+88.3%-101.4%+99.1%-104.3%+99.5%
alltimeall time-169.3%+88.3%-100.4%+99.6%-101.3%+99.5%

BIIB Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$11.70M(-49.1%)
-$33.40M(-87.5%)
Mar 2025
-
-$23.00M(-391.1%)
-$266.90M(-61.0%)
Dec 2024
-$683.50M(-598.9%)
$7.90M(-219.7%)
-$683.50M(-49.2%)
Sep 2024
-
-$6.60M(-97.3%)
-$1.35B(+173.0%)
Jun 2024
-
-$245.20M(-44.2%)
-$492.90M(+90.3%)
Mar 2024
-
-$439.60M(-32.8%)
-$259.00M(-289.1%)
Dec 2023
$137.00M(-107.8%)
-$654.20M(-177.3%)
$137.00M(-82.5%)
Sep 2023
-
$846.10M(-7587.6%)
$783.60M(-159.1%)
Jun 2023
-
-$11.30M(-74.1%)
-$1.33B(-25.8%)
Mar 2023
-
-$43.60M(+473.7%)
-$1.79B(+1.5%)
Dec 2022
-$1.76B(-15.7%)
-$7.60M(-99.4%)
-$1.76B(+1.0%)
Sep 2022
-
-$1.26B(+168.1%)
-$1.74B(+42.3%)
Jun 2022
-
-$471.50M(+2757.6%)
-$1.22B(-7.1%)
Mar 2022
-
-$16.50M(-268.4%)
-$1.32B(-36.8%)
Dec 2021
-$2.09B(-60.4%)
$9.80M(-101.3%)
-$2.09B(-16.5%)
Sep 2021
-
-$746.50M(+32.2%)
-$2.50B(-18.5%)
Jun 2021
-
-$564.50M(-28.1%)
-$3.06B(-19.6%)
Mar 2021
-
-$785.00M(+95.7%)
-$3.81B(-27.7%)
Dec 2020
-$5.27B(-10.0%)
-$401.10M(-69.4%)
-$5.27B(-24.5%)
Sep 2020
-
-$1.31B(-0.0%)
-$6.99B(+9.8%)
Jun 2020
-
-$1.31B(-41.5%)
-$6.36B(-14.3%)
Mar 2020
-
-$2.25B(+6.1%)
-$7.43B(+26.7%)
Dec 2019
-$5.86B(+31.0%)
-$2.12B(+207.2%)
-$5.86B(+13.1%)
Sep 2019
-
-$689.00M(-71.0%)
-$5.18B(+16.0%)
Jun 2019
-
-$2.38B(+249.7%)
-$4.47B(-8.5%)
Mar 2019
-
-$679.30M(-52.7%)
-$4.88B(+9.2%)
Dec 2018
-$4.47B(+87.9%)
-$1.44B(-5825.1%)
-$4.47B(+19.5%)
Sep 2018
-
$25.10M(-100.9%)
-$3.74B(-1.2%)
Jun 2018
-
-$2.79B(+939.3%)
-$3.79B(+116.8%)
Mar 2018
-
-$268.60M(-62.1%)
-$1.75B(-26.6%)
Dec 2017
-$2.38B(+140.9%)
-$708.10M(+3531.3%)
-$2.38B(-0.5%)
Sep 2017
-
-$19.50M(-97.4%)
-$2.39B(-10.5%)
Jun 2017
-
-$751.00M(-16.7%)
-$2.67B(+38.1%)
Mar 2017
-
-$901.40M(+25.0%)
-$1.94B(+86.2%)
Dec 2016
-$987.80M(-200.1%)
-$721.20M(+139.9%)
-$1.04B(-55.1%)
Sep 2016
-
-$300.60M(+2143.3%)
-$2.32B(-360.2%)
Jun 2016
-
-$13.40M(+168.0%)
$890.78M(-1.1%)
Mar 2016
-
-$5.00M(-99.7%)
$900.64M(-8.7%)
Dec 2015
$986.40M(-230.5%)
-$2.00B(-168.7%)
$986.40M(-60.1%)
Sep 2015
-
$2.91B(<-9900.0%)
$2.47B(-624.6%)
Jun 2015
-
-$3.54M(-104.4%)
-$471.17M(-40.4%)
Mar 2015
-
$80.76M(-115.7%)
-$789.99M(+4.5%)
Dec 2014
-$755.87M(+5.5%)
-$513.26M(+1361.3%)
-$755.87M(+226.6%)
Sep 2014
-
-$35.12M(-89.1%)
-$231.43M(-55.0%)
Jun 2014
-
-$322.36M(-380.6%)
-$514.83M(+41.7%)
Mar 2014
-
$114.88M(+927.4%)
-$363.23M(-49.3%)
Dec 2013
-$716.53M(-18.3%)
$11.18M(-103.5%)
-$716.53M(-3.6%)
Sep 2013
-
-$318.52M(+86.5%)
-$743.23M(+64.1%)
Jun 2013
-
-$170.76M(-28.4%)
-$452.96M(-35.3%)
Mar 2013
-
-$238.42M(+1435.8%)
-$699.64M(-20.3%)
Dec 2012
-$877.48M(+174.3%)
-$15.52M(-45.0%)
-$877.48M(-12.7%)
Sep 2012
-
-$28.25M(-93.2%)
-$1.00B(-6.6%)
Jun 2012
-
-$417.44M(+0.3%)
-$1.08B(+69.0%)
Mar 2012
-
-$416.26M(+191.5%)
-$636.29M(+98.9%)
Dec 2011
-$319.86M(-82.1%)
-$142.81M(+44.1%)
-$319.86M(-754.5%)
Sep 2011
-
-$99.13M(-552.5%)
$48.87M(-115.6%)
Jun 2011
-
$21.91M(-121.9%)
-$313.26M(-77.0%)
Mar 2011
-
-$99.83M(-144.2%)
-$1.36B(-23.7%)
Dec 2010
-$1.78B(+146.5%)
$225.93M(-149.0%)
-$1.78B(-33.4%)
Sep 2010
-
-$461.26M(-55.0%)
-$2.68B(+21.3%)
Jun 2010
-
-$1.03B(+96.0%)
-$2.21B(+87.2%)
Mar 2010
-
-$523.46M(-21.8%)
-$1.18B(+63.0%)
Dec 2009
-$724.15M(-41.4%)
-$669.59M(-7366.3%)
-$724.15M(+86.4%)
Sep 2009
-
$9.21M(+192.4%)
-$388.40M(+47.8%)
Jun 2009
-
$3.15M(-104.7%)
-$262.79M(-49.1%)
Mar 2009
-
-$66.93M(-80.0%)
-$516.07M(-58.3%)
Dec 2008
-$1.24B(+68.2%)
-$333.84M(-347.6%)
-$1.24B(+202.2%)
Sep 2008
-
$134.83M(-153.9%)
-$409.18M(-78.0%)
Jun 2008
-
-$250.13M(-68.2%)
-$1.86B(+20.3%)
Mar 2008
-
-$787.53M(-259.5%)
-$1.55B(+110.4%)
Dec 2007
-$735.22M
$493.65M(-137.5%)
-$735.22M(-36.6%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$1.32B(-2145.7%)
-$1.16B(+654.0%)
Jun 2007
-
$64.41M(+164.0%)
-$153.89M(-25.9%)
Mar 2007
-
$24.40M(-64.4%)
-$207.66M(+39.9%)
Dec 2006
-$148.41M(-84.4%)
$68.57M(-122.0%)
-$148.41M(-0.5%)
Sep 2006
-
-$311.27M(-3027.1%)
-$149.10M(-182.2%)
Jun 2006
-
$10.63M(-87.3%)
$181.46M(-125.1%)
Mar 2006
-
$83.66M(+23.2%)
-$723.69M(-23.7%)
Dec 2005
-$948.52M(+110.3%)
$67.88M(+251.9%)
-$948.52M(-3.0%)
Sep 2005
-
$19.29M(-102.2%)
-$977.74M(-25.6%)
Jun 2005
-
-$894.52M(+533.6%)
-$1.31B(+88.3%)
Mar 2005
-
-$141.18M(-465.2%)
-$698.02M(+54.8%)
Dec 2004
-$450.96M(-1945.3%)
$38.66M(-112.2%)
-$450.96M(-5.5%)
Sep 2004
-
-$317.27M(+14.0%)
-$477.10M(+203.7%)
Jun 2004
-
-$278.23M(-362.8%)
-$157.09M(-224.6%)
Mar 2004
-
$105.88M(+745.9%)
$126.05M(+415.8%)
Dec 2003
$24.44M(-95.8%)
$12.52M(+357.4%)
$24.44M(+31.6%)
Sep 2003
-
$2.74M(-44.2%)
$18.58M(-3.6%)
Jun 2003
-
$4.91M(+14.7%)
$19.27M(-96.7%)
Mar 2003
-
$4.28M(-35.7%)
$579.19M(-0.8%)
Dec 2002
$584.06M(+2035.3%)
$6.66M(+94.2%)
$584.06M(+0.5%)
Sep 2002
-
$3.43M(-99.4%)
$581.39M(+0.0%)
Jun 2002
-
$564.83M(+6075.1%)
$581.19M(+1764.4%)
Mar 2002
-
$9.15M(+129.5%)
$31.17M(+14.0%)
Dec 2001
$27.35M(-94.2%)
$3.99M(+23.6%)
$27.35M(-94.3%)
Sep 2001
-
$3.23M(-78.2%)
$481.41M(+0.0%)
Jun 2001
-
$14.81M(+178.1%)
$481.22M(+2.7%)
Mar 2001
-
$5.33M(-98.8%)
$468.55M(-0.9%)
Dec 2000
$472.63M(+277.8%)
$458.05M(>+9900.0%)
$472.63M(+2532.0%)
Sep 2000
-
$3.04M(+41.7%)
$17.96M(-5.9%)
Jun 2000
-
$2.14M(-77.2%)
$19.07M(+1.0%)
Mar 2000
-
$9.40M(+178.7%)
$18.88M(-84.9%)
Dec 1999
$125.11M(>+9900.0%)
$3.37M(-18.7%)
$125.11M(+1.6%)
Sep 1999
-
$4.15M(+113.5%)
$123.19M(+4.5%)
Jun 1999
-
$1.95M(-98.3%)
$117.89M(+1.8%)
Mar 1999
-
$115.64M(+7908.6%)
$115.79M(>+9900.0%)
Dec 1998
$538.00K(-78.1%)
$1.44M(-225.9%)
$538.00K(-98.7%)
Sep 1998
-
-$1.15M(+644.8%)
$40.79M(-2.7%)
Jun 1998
-
-$154.00K(-139.0%)
$41.94M(+83.2%)
Mar 1998
-
$395.00K(-99.1%)
$22.89M(-65.3%)
Dec 1997
$2.46M(-96.2%)
$41.70M(>+9900.0%)
$65.90M(+64.4%)
Sep 1997
-
$0.00(-100.0%)
$40.07M(-21.8%)
Jun 1997
-
-$19.20M(-144.2%)
$51.27M(-38.7%)
Mar 1997
-
$43.40M(+173.4%)
$83.67M(+61.6%)
Dec 1996
$64.46M(+885.0%)
$15.87M(+41.7%)
$51.77M(-16.0%)
Sep 1996
-
$11.20M(-15.2%)
$61.65M(-13.0%)
Jun 1996
-
$13.20M(+14.8%)
$70.85M(+18.6%)
Mar 1996
-
$11.50M(-55.3%)
$59.75M(-19.2%)
Dec 1995
$6.54M(-60.0%)
$25.75M(+26.2%)
$73.95M(+50.8%)
Sep 1995
-
$20.40M(+871.4%)
$49.05M(+46.6%)
Jun 1995
-
$2.10M(-91.8%)
$33.45M(-14.3%)
Mar 1995
-
$25.70M(+2941.4%)
$39.05M(+151.2%)
Dec 1994
$16.37M(+212.0%)
$845.00K(-82.4%)
$15.54M(-15.5%)
Sep 1994
-
$4.80M(-37.7%)
$18.40M(+21.9%)
Jun 1994
-
$7.70M(+250.0%)
$15.10M(+69.7%)
Mar 1994
-
$2.20M(-40.5%)
$8.90M(+14.1%)
Dec 1993
$5.25M(+241.2%)
$3.70M(+146.7%)
$7.80M(-28.4%)
Sep 1993
-
$1.50M(0.0%)
$10.90M(-5.2%)
Jun 1993
-
$1.50M(+36.4%)
$11.50M(+8.5%)
Mar 1993
-
$1.10M(-83.8%)
$10.60M(+6.0%)
Dec 1992
$1.54M(-97.2%)
$6.80M(+223.8%)
$10.00M(-88.7%)
Sep 1992
-
$2.10M(+250.0%)
$88.30M(-0.5%)
Jun 1992
-
$600.00K(+20.0%)
$88.70M(+1.1%)
Mar 1992
-
$500.00K(-99.4%)
$87.70M(+1.4%)
Dec 1991
$54.72M(-3140.0%)
$85.10M(+3304.0%)
$86.50M(>+9900.0%)
Sep 1991
-
$2.50M(-725.0%)
$100.00K(-105.3%)
Jun 1991
-
-$400.00K(-42.9%)
-$1.90M(+18.8%)
Mar 1991
-
-$700.00K(-46.2%)
-$1.60M(-11.1%)
Dec 1990
-$1.80M(-102.8%)
-$1.30M(-360.0%)
-$1.80M(+260.0%)
Sep 1990
-
$500.00K(-600.0%)
-$500.00K(-50.0%)
Jun 1990
-
-$100.00K(-88.9%)
-$1.00M(+11.1%)
Mar 1990
-
-$900.00K
-$900.00K
Dec 1989
$64.50M
-
-

FAQ

  • What is Biogen Inc. annual cash flow from financing activities?
  • What is the all time high annual CFF for Biogen Inc.?
  • What is Biogen Inc. annual CFF year-on-year change?
  • What is Biogen Inc. quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Biogen Inc.?
  • What is Biogen Inc. quarterly CFF year-on-year change?
  • What is Biogen Inc. TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Biogen Inc.?
  • What is Biogen Inc. TTM CFF year-on-year change?

What is Biogen Inc. annual cash flow from financing activities?

The current annual CFF of BIIB is -$683.50M

What is the all time high annual CFF for Biogen Inc.?

Biogen Inc. all-time high annual cash flow from financing activities is $986.40M

What is Biogen Inc. annual CFF year-on-year change?

Over the past year, BIIB annual cash flow from financing activities has changed by -$820.50M (-598.91%)

What is Biogen Inc. quarterly cash flow from financing activities?

The current quarterly CFF of BIIB is -$11.70M

What is the all time high quarterly CFF for Biogen Inc.?

Biogen Inc. all-time high quarterly cash flow from financing activities is $2.91B

What is Biogen Inc. quarterly CFF year-on-year change?

Over the past year, BIIB quarterly cash flow from financing activities has changed by +$233.50M (+95.23%)

What is Biogen Inc. TTM cash flow from financing activities?

The current TTM CFF of BIIB is -$33.40M

What is the all time high TTM CFF for Biogen Inc.?

Biogen Inc. all-time high TTM cash flow from financing activities is $2.47B

What is Biogen Inc. TTM CFF year-on-year change?

Over the past year, BIIB TTM cash flow from financing activities has changed by +$459.50M (+93.22%)
On this page